[Late effects of mammary radiotherapy on skin and subcutaneous tissues].
Late damages to the skin and subcutaneous tissues are almost inescapable because of the high skin doses required in the irradiation of breast tumours. While the clinical and histological descriptions date back to the first decades of the therapeutic use of ionising radiation, the recent advances in cellular and molecular biology have significantly contributed to the increased understanding of late skin injury mechanisms. In particular, sub-cutaneous fibrosis appears to be the partly reversible results of a continuous and self-maintained local process, possibly sensitive to therapeutic intervention. A second very active research avenue is the development of biologic assays potentially able to predict the probability of increased normal tissue injury after irradiation in individual patients. Such a test would allow the adaptation of the treatment modalities to the radiobiological behaviour of normal tissues. To date, these expectations have not been met. The quality of the irradiation and its modalities (total dose, fractionation, inter fraction interval) remain the main ways to achieve an optimal functional and cosmetic outcome.
Dubray
B
B
Département d'oncologie-radiothérapie, institut Curie, Paris, France.
Delanian
S
S
Lefaix
J L
JL
D001943:Breast Neoplasms / Q000532:radiotherapy*; D019583:Dose Fractionation, Radiation; D004307:Dose-Response Relationship, Radiation; D005260:Female; D005355:Fibrosis / Q000209:etiology / Q000628:therapy; D006801:Humans; D007249:Inflammation / Q000209:etiology / Q000628:therapy; D011836:Radiation Tolerance; D011878:Radiotherapy / Q000009:adverse effects* / Q000379:methods; D011879:Radiotherapy Dosage; D012867:Skin / Q000473:pathology / Q000528:radiation effects*; D013997:Time Factors
Effets tardifs de la radiothérapie mammaire sur la peau et les tissus sous-cutanés.